Flick Gocke Schaumburg advises medavis on the acquisition of medDream

Flick Gocke Schaumburg has advised the medavis Group on the acquisition of the business operations relating to the product medDream Viewer from Softneta UAB.

medDream thus becomes part of the medavis Group and adds an innovative medical viewer to its portfolio. It can be used widely in various medical disciplines. At the same time, it will become a key component of the medavis referral and patient portal, thus supporting the entire treatment pathway for patients.

The medDream Viewer is certified as a Class IIB medical device in accordance with the European Medical Device Regulation (MDR) and is approved by the US FDA for diagnostic purposes and certified for other countries.

Advisors to medavis GmbH: Flick Gocke Schaumburg

Mathias Bülow (project lead), Justus Bode, associate: Dr. Golo Meven (all private equity/M&A)

Led by Mathias Bülow, teams from Flick Gocke Schaumburg regularly advise portfolio companies of funds advised by Bregal Unternehmerkapital AG (BU). Most recently, these teams assisted medavis in its mergers with both InformMe GmbH and Digithurst, and advised the BuildTec Group on the integration of Hausmann Wynen and the conclusion of a partnership with Glaser GmbH.

The medavis Group, based in Karlsruhe, is a medium-sized company that has specialized in process optimization in radiology for 25 years and is a leading provider of specialist radiology software for practising radiologists, radiology practice groups and hospitals. The majority shareholders of medavis are funds advised by BU.

BU is a leading investment company of the CEE region with offices in Munich, Zug and Milan. Its funds invest in medium-sized companies headquartered in Germany, Austria, Switzerland and northern Italy. Since it was founded in 2015, the funds advised by BU have invested over EUR 3 billion in more than 110 companies. BU currently manages around EUR 7 billion (including binding capital commitments).

Softneta specialises in medical imaging and communication solutions. The company was founded in Lithuania in 2007 and has more than 17 years of experience in the development of medical devices for the processing, visualisation and transmission of diagnostic medical data.

Flick Gocke Schaumburg advises medavis on the acquisition of medDream

Berlin, July 4, 2024 – Flick Gocke Schaumburg has advised the medavis Group on the acquisition of the business operations relating to the product medDream Viewer from Softneta UAB.

medDream thus becomes part of the medavis Group and adds an innovative medical viewer to its portfolio. It can be used widely in various medical disciplines. At the same time, it will become a key component of the medavis referral and patient portal, thus supporting the entire treatment pathway for patients.

The medDream Viewer is certified as a Class IIB medical device in accordance with the European Medical Device Regulation (MDR) and is approved by the US FDA for diagnostic purposes and certified for other countries.

Advisors to medavis GmbH: Flick Gocke Schaumburg

Mathias Bülow (project lead), Justus Bode, associate: Dr. Golo Meven (all private equity/M&A)

Led by Mathias Bülow, teams from Flick Gocke Schaumburg regularly advise portfolio companies of funds advised by Bregal Unternehmerkapital AG (BU). Most recently, these teams assisted medavis in its mergers with both InformMe GmbH and Digithurst, and advised the BuildTec Group on the integration of Hausmann Wynen and the conclusion of a partnership with Glaser GmbH.

The medavis Group, based in Karlsruhe, is a medium-sized company that has specialized in process optimization in radiology for 25 years and is a leading provider of specialist radiology software for practising radiologists, radiology practice groups and hospitals. The majority shareholders of medavis are funds advised by BU.

BU is a leading investment company of the CEE region with offices in Munich, Zug and Milan. Its funds invest in medium-sized companies headquartered in Germany, Austria, Switzerland and northern Italy. Since it was founded in 2015, the funds advised by BU have invested over EUR 3 billion in more than 110 companies. BU currently manages around EUR 7 billion (including binding capital commitments).

Softneta specialises in medical imaging and communication solutions. The company was founded in Lithuania in 2007 and has more than 17 years of experience in the development of medical devices for the processing, visualisation and transmission of diagnostic medical data.

Flick Gocke Schaumburg advises medavis on the acquisition of medDream

Berlin, July 4, 2024 – Flick Gocke Schaumburg has advised the medavis Group on the acquisition of the business operations relating to the product medDream Viewer from Softneta UAB.

medDream thus becomes part of the medavis Group and adds an innovative medical viewer to its portfolio. It can be used widely in various medical disciplines. At the same time, it will become a key component of the medavis referral and patient portal, thus supporting the entire treatment pathway for patients.

The medDream Viewer is certified as a Class IIB medical device in accordance with the European Medical Device Regulation (MDR) and is approved by the US FDA for diagnostic purposes and certified for other countries.

Advisors to medavis GmbH: Flick Gocke Schaumburg

Mathias Bülow (project lead), Justus Bode, associate: Dr. Golo Meven (all private equity/M&A)

Led by Mathias Bülow, teams from Flick Gocke Schaumburg regularly advise portfolio companies of funds advised by Bregal Unternehmerkapital AG (BU). Most recently, these teams assisted medavis in its mergers with both InformMe GmbH and Digithurst, and advised the BuildTec Group on the integration of Hausmann Wynen and the conclusion of a partnership with Glaser GmbH.

The medavis Group, based in Karlsruhe, is a medium-sized company that has specialized in process optimization in radiology for 25 years and is a leading provider of specialist radiology software for practising radiologists, radiology practice groups and hospitals. The majority shareholders of medavis are funds advised by BU.

BU is a leading investment company of the CEE region with offices in Munich, Zug and Milan. Its funds invest in medium-sized companies headquartered in Germany, Austria, Switzerland and northern Italy. Since it was founded in 2015, the funds advised by BU have invested over EUR 3 billion in more than 110 companies. BU currently manages around EUR 7 billion (including binding capital commitments).

Softneta specialises in medical imaging and communication solutions. The company was founded in Lithuania in 2007 and has more than 17 years of experience in the development of medical devices for the processing, visualisation and transmission of diagnostic medical data. <<<